Loading the section
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | Dec 31, 2025 | Dec 31, 2024 |
|---|---|---|
| Revenue | 14.80bn | 13.70bn |
| Research and development | 521m | 491m |
| Selling, general and administrative | 1.17bn | 1.16bn |
| Pre-tax income | 1.14bn | 943m |
| Income tax | 214m | 118m |
| Net income | 921m | 824m |
| Earnings per share | 5.15 | 4.38 |
| Earnings per share, diluted | 5.11 | 4.33 |
| Metric | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 1.61bn | 2.03bn | 1.52bn | 1.43bn | 1.25bn | 1.44bn | 1.35bn | 1.41bn |
| Inventory | 4.56bn | 4.28bn | 4.46bn |
| Metric | Dec 31, 2025 | Dec 31, 2024 |
|---|---|---|
| Operating cash flow | 1.31bn | 1.01bn |
| Depreciation and amortisation | 401m | 382m |
| Capital expenditure | 383m | 364m |
| Investing cash flow | −207m | −284m |
| Dividends paid | 18m | 12m |
| Share buybacks | 822m |
Amounts in USD unless stated otherwise. Sources: Nasdaq Trader, Yahoo Finance, U.S. Securities and Exchange Commission (EDGAR)
| 4.34bn |
| 4.27bn |
| 4.07bn |
| 4.41bn |
| 4.38bn |
| Total assets | 18.14bn | 18.13bn | 17.38bn | 17.08bn | 16.94bn | 16.84bn | 16.45bn | 16.43bn |
| Total liabilities | 10.14bn | 10.25bn | 9.89bn | 9.64bn | 9.67bn | 9.63bn | 9.50bn | 9.58bn |
| Equity | 8.00bn | 7.88bn | 7.49bn | 7.43bn | 7.28bn | 7.20bn | 6.95bn | 6.85bn |
| Shares outstanding | 174m | 174m | 176m | 178m | 181m | 183m | 186m | 187m |
| Shares issued | — | 175m | — | — | — | 184m | — | — |
| 1.12bn |
| Financing cash flow | −543m | −1.45bn |